HHS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
38.0M
+1.9%
37.3M
-6.5%
39.9M
+0.9%
39.5M
+2.3%
38.6M
Cost of Revenue
0
0
0
0
0
Gross Profit
38.0M
+1.9%
37.3M
-6.5%
39.9M
+0.9%
39.5M
+2.3%
38.6M
Operating Expenses
42.5M
+11.7%
38.0M
-4.9%
40.0M
+2.5%
39.0M
+1.1%
38.6M
R&D
0
0
0
0
0
SG&A
41.2M
+11.9%
36.8M
-4.7%
38.6M
+3.6%
37.3M
-0.3%
37.4M
Operating Income
-4490000
-484.6%
-768000
-556.4%
-117000
-123.0%
509.0K
+1397.1%
34.0K
EBITDA
-3181000
-771.1%
474.0K
-62.6%
1.3M
-44.1%
2.3M
+81.5%
1.2M
Net Income
-5003000
-696.7%
-628000
-128.5%
2.2M
+196.3%
-2286000
-582.4%
-335000
EPS (Basic)
$-0.67
-737.5%
$-0.08
-126.7%
$0.30
+196.8%
$-0.31
-520.0%
$-0.05
EPS (Diluted)
$-0.67
-737.5%
$-0.08
-126.7%
$0.30
+196.8%
$-0.31
-520.0%
$-0.05
Shares (Diluted)
7.4M
+0.2%
7.4M
+0.0%
7.4M
+0.0%
7.4M
+0.4%
7.4M
Harte-Hanks (HHS) โ€” Financials